Daiwa Securities Group Inc. - IONIS PHARMACEUTICALS INC ownership

IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 306 filers reported holding IONIS PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.70 and the average weighting 0.2%.

Quarter-by-quarter ownership
Daiwa Securities Group Inc. ownership history of IONIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$23
+9.5%
5150.0%0.00%
Q2 2023$21
+5.0%
515
-9.8%
0.00%
Q1 2023$20
-9.1%
5710.0%0.00%
Q4 2022$22
-99.9%
571
+8.1%
0.00%
Q3 2022$23,000
+15.0%
5280.0%0.00%
Q2 2022$20,000
+33.3%
528
+28.2%
0.00%
Q1 2022$15,000
+15.4%
4120.0%0.00%
Q4 2021$13,000
-18.8%
412
-14.7%
0.00%
Q3 2021$16,000
+45.5%
483
+73.1%
0.00%
Q2 2021$11,000
-95.8%
279
-95.2%
0.00%
-100.0%
Q1 2021$260,000
-20.2%
5,776
+0.3%
0.00%
-33.3%
Q4 2020$326,000
+9.0%
5,760
-8.4%
0.00%0.0%
Q3 2020$299,000
+1.4%
6,291
+0.7%
0.00%
-50.0%
Q2 2020$295,0000.0%6,2480.0%0.01%
+100.0%
Q1 2020$295,000
-15.2%
6,248
+8.5%
0.00%0.0%
Q4 2019$348,000
-0.9%
5,759
-1.7%
0.00%0.0%
Q3 2019$351,000
-6.4%
5,860
+0.3%
0.00%0.0%
Q2 2019$375,000
+428.2%
5,840
+567.4%
0.00%
+200.0%
Q1 2019$71,000
+47.9%
875
-1.7%
0.00%
Q4 2018$48,000
+33.3%
890
+29.0%
0.00%
Q3 2018$36,000
+24.1%
6900.0%0.00%
Q2 2018$29,000
-3.3%
6900.0%0.00%
Q1 2018$30,000
-53.8%
690
-75.4%
0.00%
Q2 2016$65,000
-42.5%
2,8000.0%0.00%
-100.0%
Q1 2016$113,000
-34.7%
2,8000.0%0.00%0.0%
Q4 2015$173,0002,8000.00%
Other shareholders
IONIS PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
BB BIOTECH AG 6,529,838$404,393,00011.39%
DOWLING & YAHNKE LLC 676,379$41,888,0005.27%
Opus Point Partners Management, LLC 102,459$6,345,0004.19%
WILLIAM HARRIS INVESTORS INC 230,443$14,271,0003.43%
PINNACLE ASSOCIATES LTD 1,690,263$104,678,0002.20%
MESSNER & SMITH THEME VALUE INVESTMENT MANAGEMENT LTD /CA/ 21,298$1,319,0002.11%
Sonora Investment Management, LLC 126,763$7,850,0002.04%
Virtus ETF Advisers LLC 10,447$647,0001.78%
Apex Capital Management 1,020,096$63,175,0001.41%
PERKINS CAPITAL MANAGEMENT INC 19,900$1,232,0001.32%
View complete list of IONIS PHARMACEUTICALS INC shareholders